Volunteers gathered at the Texas Tech Federal Credit Union Thursday for the Lubbock Walk to End Alzheimer’s® Kick-Off Event.

The AFA opens a new Alzheimer’s support center in Amityville, offering programs, memory screenings and caregiver respite for ...

Amityville’s new Barbara Rabinowitz Education & Resource Center includes even a special transit-focused room to teach ...

TOLEDO, Ohio — As June is Alzheimer's and Brain Awareness Month, the Alzheimer's Association is encouraging everyone to wear purple as a simple and small reminder to think about brain health ...

An existing drug for HIV could double as a preventative therapy for Alzheimer’s disease, according to researchers. NRTIs (nucleoside reverse transcriptase inhibitors) are antivirals that are ...

Omega-3 fatty acids, huperzine A, and synthetic coenzyme Q10 have been proven in clinical trials to be no better than placebo (i.e., like a sugar pill) for Alzheimer's disease patients, according ...

With the number of Americans living with the disease steadily increasing, scientists predict that 13.8 million will have Alzheimer’s by 2050, or 16% of the US population over the age of 65.

While Alzheimer’s is a specific disease and the most common cause of dementia, dementia is a broader, "umbrella term that describes a collection of cognitive, functional and behavioral symptoms ...

Lead researcher Dr. Andrea Castegnaro of the UCL Institute of Cognitive Neuroscience commented in 2023 upon concluding the study, highlighting navigation as a key early symptom of Alzheimer’s ...

Alzheimer’s disease now affects more than seven million people in the U.S., and nearly four in five Americans say they would want to know if they have it before symptoms emerge. This data comes ...

Disproven alternative therapies for treating cognitive symptoms in Alzheimer's disease include omega-3 fatty acids, huperzine A, and synthetic coenzyme Q10, according to the Alzheimer's Association.

A cholinergic agonist first developed in the 1990s for Alzheimer’s disease, xanomeline, was approved last year in combination with trospium chloride, a side-effect blocker, for the treatment of ...